您好,欢迎来到科研在线!科研采购 · 选型 · 实验方法
首页产品库品牌馆产品类别品牌新闻会议会展产品试用求职招聘资讯专题教程
PRO / Antibodies

In Vivo Star Anti-Mouse VEGF Antibody

In Vivo Star Anti-Mouse VEGF Antibody

英诺赛图(InnoCyto)的 In Vivo Star Anti-Mouse VEGF Antibody(克隆 B20-4.1.1) 为鼠源 IgG2a Kappa 抗体,靶向 Mouse。提供 1 mg、5 mg、25 mg 规格,目录价 ¥1,085 起,仅供科研使用(RUO)。

生物试剂 供应商 上海英诺赛图 ↗ 型号 512901 更新 2026-11-12
参考价格区间
¥1,085
含税参考价,实际以配置与渠道报价为准
本条目供应商 上海英诺赛图原厂 1865个条目 进入企业主页

01产品图片

02产品简介

英诺赛图(InnoCyto)的 In Vivo Star Anti-Mouse VEGF Antibody(克隆 B20-4.1.1) 为鼠源 IgG2a Kappa 抗体,靶向 Mouse。提供 1 mg、5 mg、25 mg 规格,目录价 ¥1,085 起,仅供科研使用(RUO)。

03产品介绍

规格与货号

512901 | 1 mg | ¥1,085

512902 | 5 mg | ¥2,712

512903 | 25 mg | ¥7,458

513001 | 1 mg | ¥1,085

513002 | 5 mg | ¥2,712

513003 | 25 mg | ¥7,458

513101 | 1 mg | ¥1,085

513102 | 5 mg | ¥2,712

513103 | 25 mg | ¥7,458

Product Details

Application|ELISA, WB, Flow cytometry, IHC, ICC, animal model study

Target Name|Vascular endothelial growth factor, VEGF-A, VEGFA, VEGF

Product Description|In Vivo Grade Recombinant Anti-mouse VEGF Monoclonal Antibody

Regulatory Status|RUO

Endotoxin

Storage Conditions|4ºC

Recommended Usage|This product is suitable for in vivo animal use. Optimal amounts need to be determined empirically for each experiment.

See All Formats|Clone B20-4.1.1

Background Information

Vascular Endothelial Growth Factor (VEGF) is a potent signaling protein that plays a central role in angiogenesis - the formation of new blood vessels from existing vasculature. It is essential during embryonic development, wound healing, and tissue regeneration, serving as a key regulator of vascular permeability and endothelial cell proliferation. In adults, VEGF facilitates physiological angiogenesis in the ovary, endometrium, and skeletal muscle but also contributes to various pathological processes when dysregulated.

Structurally, VEGF belongs to a larger family of growth factors that includes VEGF-A, VEGF-B, VEGF-C, VEGF-D, and Placental Growth Factor (PlGF). The prototype, VEGF-A, is a homodimeric glycoprotein composed of two approximately 23-kDa subunits linked by disulfide bonds. Alternative splicing of the VEGF-A gene gives rise to multiple isoforms (such as VEGF121, VEGF165, and VEGF189), each differing in heparin-binding affinity and bioavailability. These isoforms allow for fine-tuned regulation of angiogenic signaling within different tissues and physiological contexts.

VEGF family members function by binding to high-affinity tyrosine kinase receptors on endothelial cells: VEGFR-1 (Flt-1), VEGFR-2 (KDR/Flk-1), and VEGFR-3 (Flt-4), in conjunction with co-receptors like neuropilins (NRP-1 and NRP-2). Among these, VEGFR-2 mediates most of the pro-angiogenic effects, triggering intracellular signaling cascades such as the PI3K/Akt and MAPK pathways, which promote endothelial cell survival, proliferation, migration, and vascular permeability.

Dysregulation of VEGF signaling is implicated in numerous diseases. Overexpression of VEGF drives pathological angiogenesis in cancers, diabetic retinopathy, and age-related macular degeneration (AMD). Tumors exploit VEGF signaling to establish a blood supply, providing oxygen and nutrients necessary for growth and metastasis. Conversely, insufficient VEGF expression can lead to impaired wound healing and ischemic diseases due to poor blood vessel development.

Therapeutically, VEGF and its receptors are major targets in modern medicine. Anti-VEGF therapies aim to inhibit excessive angiogenesis and restore vascular balance. Bevacizumab (Avastin), a monoclonal antibody against VEGF-A, was the first anti-angiogenic therapy approved for cancer treatment. Other agents, such as ranibizumab (Lucentis) and aflibercept (Eylea), are widely used in ophthalmology to treat AMD and diabetic macular edema by preventing abnormal vascular leakage and neovascularization in the retina. Additionally, small-molecule inhibitors targeting VEGFR tyrosine kinases, such as sunitinib, sorafenib, and pazopanib, are employed in cancer therapy to block downstream VEGF signaling pathways. Collectively, VEGF-targeted therapies have transformed the treatment landscape of cancer and ocular diseases but continue to be refined to minimize toxicities and resistance mechanisms.

Data Sheets

Cat # Size Price Quantity 5129011 mg Add to Cart5129025 mg Add to Cart51290325 mg Add to Cart

04完整参数表

参数由厂商资料整理,采购前请以最终报价单与技术协议为准。

包装规格1 mg
CloneB20-4.1.1
Host SpeciesCHO cells
ReactivityMouse
FormatLiquid
Product DescriptionIn Vivo Grade Recombinant Anti-mouse VEGF Monoclonal Antibody
IsotypeMouse IgG2a Kappa
Antibody TypeRecombinant
Regulatory StatusRUO
Purity>95% by reducing SDS-PAGE
Storage Conditions4ºC
GradeIn vivo
Recommended UsageThis product is suitable for in vivo animal use. Optimal amounts need to be determined empirically for each experiment.
RRIDAB_3739403
目录价¥1,085

05荣誉与资质

该品牌暂未上传荣誉证书与资质文件。以下是平台可核验的公开信息,未上传项如实标注,不做推断。

  • 营业执照未上传
  • 品牌授权未上传
  • 产品检测报告未上传
会员身份
收费会员
经营身份
原厂
成立年份
2020 年
所在地
上海
收录条目
1865 个
平台核验
平台代管
向品牌方索取资质文件

06品牌与供应商

上海英诺赛图 原厂
InnoCyto

以可信赖的细胞研究试剂,助力科研突破

进入企业主页
1865 本目录条目
产地 / 总部上海市浦东新区
成立年份2020 年
本目录主营生化试剂 / 蛋白与抗体

InnoCyto(上海英诺赛图生物科技有限公司)致力于通过开发高质量细胞分析试剂,加速科学发现进程。公司为研究人员提供细胞层面探索所需的工具,推动免疫学、肿瘤学等多领域的研究创新。 核心团队拥有丰富的行业经验,曾参与全球头部生命科学公司的标杆项目搭建,深刻理解工业界与学术研究的前沿需求。试剂从设计之初即以精确性、一致性、高性能为核心标准,让科学家能把精力集中在最核心的研究工作上。 公司将深厚的科学积累与对品质的严格承诺相结合,力争成为全球研究人员信赖的合作伙伴。产品线覆盖经验证的一抗与二抗、同型对照、生物类似药抗体、重组蛋白、细胞因子、免疫检测试剂盒及配套试剂,并提供重组蛋白/抗体表达与标记偶联服务。

售后与服务

品牌资料由厂商公开信息与授权渠道核对整理;条目参数与价格以最终报价单为准。

引用此条目 产品目录 · 更新于 2026-11-12
科研在线(TeleVM). In Vivo Star Anti-Mouse VEGF Antibody(512901)[EB/OL]. 产品目录, 2026-11-12. https://www.suprotek.cn/products/item/in-vivo-star-anti-mouse-vegf-antibody.html.
TeleVM. (2026, November 12). In Vivo Star Anti-Mouse VEGF Antibody(512901). 产品目录. https://www.suprotek.cn/products/item/in-vivo-star-anti-mouse-vegf-antibody.html
@misc{biocsp_item_in_vivo_star_anti_mouse_vegf_antibody,
  title        = {In Vivo Star Anti-Mouse VEGF Antibody(512901)},
  author       = {{科研在线}},
  year         = {2026},
  howpublished = {产品目录},
  note         = {更新于 2026-11-12,产品目录},
  url          = {https://www.suprotek.cn/products/item/in-vivo-star-anti-mouse-vegf-antibody.html}
}

GB/T 7714 用于中文论文与报告;APA 7 用于英文期刊;BibTeX 可直接导入 Zotero、EndNote 或 LaTeX。

许可:CC BY-NC 4.0 · 转载注明来源
获取正式报价

In Vivo Star Anti-Mouse VEGF Antibody

提交后由平台转给品牌方,通常 1 个工作日内联系。不需要注册。